Golden Sun Health Technology Group Limited

NasdaqCM:GSUN Stock Report

Market Cap: US$3.1m

Golden Sun Health Technology Group Management

Management criteria checks 2/4

Golden Sun Health Technology Group's CEO is Xueyuan Weng, appointed in Nov 2020, has a tenure of 7.17 years. total yearly compensation is $44.19K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 18.74% of the company’s shares, worth $572.26K. The average tenure of the management team and the board of directors is 1.2 years and 2.3 years respectively.

Key information

Xueyuan Weng

Chief executive officer

US$44.2k

Total compensation

CEO salary percentage100.00%
CEO tenure5yrs
CEO ownership18.7%
Management average tenure1.2yrs
Board average tenure2.3yrs

Recent management updates

Recent updates

Positive Sentiment Still Eludes Golden Sun Health Technology Group Limited (NASDAQ:GSUN) Following 28% Share Price Slump

Nov 12
Positive Sentiment Still Eludes Golden Sun Health Technology Group Limited (NASDAQ:GSUN) Following 28% Share Price Slump

Why Investors Shouldn't Be Surprised By Golden Sun Health Technology Group Limited's (NASDAQ:GSUN) 28% Share Price Plunge

Aug 08
Why Investors Shouldn't Be Surprised By Golden Sun Health Technology Group Limited's (NASDAQ:GSUN) 28% Share Price Plunge

Benign Growth For Golden Sun Health Technology Group Limited (NASDAQ:GSUN) Underpins Its Share Price

Jun 11
Benign Growth For Golden Sun Health Technology Group Limited (NASDAQ:GSUN) Underpins Its Share Price

There's Reason For Concern Over Golden Sun Education Group Limited's (NASDAQ:GSUN) Price

Jun 19
There's Reason For Concern Over Golden Sun Education Group Limited's (NASDAQ:GSUN) Price

Golden Sun Education Group GAAP EPS of $0.02, revenue of $7.21M

Aug 16

Golden Sun Education Shines Brightly In New York Trading Debut

Jun 24

CEO Compensation Analysis

How has Xueyuan Weng's remuneration changed compared to Golden Sun Health Technology Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

-US$8m

Dec 31 2024n/an/a

-US$6m

Sep 30 2024US$44kUS$44k

-US$4m

Jun 30 2024n/an/a

-US$3m

Mar 31 2024n/an/a

-US$3m

Dec 31 2023n/an/a

-US$4m

Sep 30 2023US$53kUS$53k

-US$6m

Jun 30 2023n/an/a

-US$6m

Mar 31 2023n/an/a

-US$6m

Dec 31 2022n/an/a

-US$4m

Sep 30 2022US$358kUS$58k

-US$2m

Compensation vs Market: Xueyuan's total compensation ($USD44.19K) is below average for companies of similar size in the US market ($USD586.50K).

Compensation vs Earnings: Xueyuan's compensation has been consistent with company performance over the past year.


CEO

Xueyuan Weng (60 yo)

5yrs
Tenure
US$44,189
Compensation

Mr. Xueyuan Weng is Chairman and Chief Executive Officer at Golden Sun Health Technology Group Limited (formerly known as Golden Sun Education Group Limited) since November 2020 and serves as its Director...


Leadership Team

NamePositionTenureCompensationOwnership
Xueyuan Weng
Chairman & CEO5yrsUS$44.19k18.74%
$ 572.3k
Yu Sun
Chief Financial Officer1.2yrsUS$43.53kno data
Duo Ye
Chief Operating Officerless than a yearno datano data
Lizhen Wang
Chief Technology Officerno datano datano data
1.2yrs
Average Tenure
47yo
Average Age

Experienced Management: GSUN's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Xueyuan Weng
Chairman & CEO7.2yrsUS$44.19k18.74%
$ 572.3k
Xiao Jin
Independent Director1.8yrsno datano data
Peilin Ji
Director5yrsno data9.67%
$ 295.4k
Liming Xu
Director5yrsUS$26.88k3.02%
$ 92.3k
Yidong Hao
Independent Director2.3yrsno datano data
Zhenghua Yu
Independent Director2.3yrsno datano data
Xijing Xu
Independent Director1.3yrsno datano data
2.3yrs
Average Tenure
60yo
Average Age

Experienced Board: GSUN's board of directors are not considered experienced ( 2.3 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/29 02:26
End of Day Share Price 2025/11/28 00:00
Earnings2025/03/31
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Golden Sun Health Technology Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.